U.S. Markets closed

iBrands Corp. (IBRC)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.0000-0.0001 (-99.00%)
At close: 10:21AM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close0.0001
Open0.0000
Bid0.0000 x 0
Ask0.0000 x 0
Day's Range0.0000 - 0.0001
52 Week Range0.0000 - 0.0028
Volume9,400,812
Avg. Volume3,449,549
Market Cap20,248
Beta (5Y Monthly)5.79
PE Ratio (TTM)N/A
EPS (TTM)-0.2130
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • GlobeNewswire

    iBrands Corporation Appoints New CEO And Changes Business Focus

    LAS VEGAS, June 07, 2021 (GLOBE NEWSWIRE) -- iBrands Corporation (OTC: IBRC) (“the Company”), a diversified holdings company, is pleased to announce the appointment of Billionaire Frank Ekejija as its new Chairman, President and CEO and changed the company’s business focus, respectively. “iBrands Corporation has an enormous intrinsic value because we have loaded the basis for the benefit of the shareholders and stakeholders. Moving forward the company will be engaged in providing Merchant / Priv

  • GlobeNewswire

    iBrands Corporation Launches Nano Sport Nutraceutical

    LAS VEGAS, May 10, 2021 (GLOBE NEWSWIRE) -- (OTC PINK: IBRC) ("the Company"), a diversified holding and branding company, announces that through its subsidiary iBrands Farms, has launched Nano Sport, a Nano Stilbene and Nano Cannabidiol based nutraceutical product. Nano Cannabidiol is a proprietary formulation of nano particle cannabidiol isolate in the range of 75-90 nanometers at a concentration of 200mg per milliliter. Nano Cannabidiol has been engineered to cross the brain-blood-barrier as both an oral formulation and as an intranasal delivery. "Cannabidiol (commonly referred to as CBD) is a phytocannabinoid derived from USDA Hemp stock, and is devoid of psychoactive activity, while at the same time has analgesic, anti-inflammatory, antineoplastic and chemo preventive activities," said Timothy Dixon, President and CEO of TSOI. "The product Nano Sport is blended on a 50/50 ratio with patented "NanoStilbene." This new blend is free from air, light, and hard environment, and as a delivery system it improves the bioavailability of both pterostilbene and cannabidiol while providing sustained release at the same time,” added Mr. Dixon, CEO of Therapeutic Solutions International. The company's subsidiary iBrands Farms, recently has become a product sponsor for the Ontario Bandits Football Club and will be providing its nutraceutical supplements to the players and staff. “We are excited to see the benefits of these nutraceutical products on our players and staff in hopes that it will enhance performance and generate wins,” said Ontario Bandits President Patrick Johnson. "Having verified nanoparticle lengths of the pterostilbene in the 75-90nm (nanometer) range and the cannabidiol in same range we are excited to offer this blend under the Nano Sport label. To put this in perspective the thickness of a single human hair measures approximately 75,000 nm across, meaning 750 of our nanoparticles lined up side-by-side would fit in the diameter of a human hair," said Thomas Ichim, PhD, Director of Therapeutic Solutions International and co-inventor. "In our opinion, the small size, combined with the stability of the formulation, positions our NanoStilbene and Nano Cannabidiol product as second-to-none in terms of effectively delivering the compound for a variety of uses." The Ontario Bandits became the newest expansion team for the National Arena League (NAL) as the league previously announced recent expansion with the Albany Empire as its New York based franchise this previous October. The Bandits will be the seventh team entering the 2021 season with the NAL joining the Jacksonville Sharks, Columbus Lions, Carolina Cobras, Orlando Predators, Jersey Flight, and the Albany Empire. These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease. About the Ontario Bandits Football Club The Ontario Bandits Football Club is a sports and entertainment property located in Southern California that is committed to exhibiting hard work and excellence both on the field and off in our respective communities. For more information please go to: https://www.toyota-arena.com/teams/detail/ontario-banditshttps://www.ontariobandits.com/ BUY BANDITS GAME TICKETS ! About Therapeutic Solutions International, Inc. Therapeutic Solutions International is focused on immune modulation for the treatment of several specific diseases. Immune modulation refers to the ability to upregulate (make more active) or downregulate (make less active) one's immune system. The Company's corporate website is at www.therapeuticsolutionsint.com and our e-commerce is at www.youcanordernow.com and for additional info on NanoStilbene visit www.nanostilbene.com. About iBrands Farms iBrands Farms is a vertically integrated agribusiness focused on the production and sale of products with naturally occurring cannabinoids. Our mission is to efficiently deliver the highest quality industrial hemp-derived cannabinoid products and unique nutraceuticals to our customers, both retail and wholesale. The company can be found at www.ibrandsfarms.com About iBrands Corporation iBrands Corporation, Inc. is a holding and branding company that acquires and operates niche market brands that have unique market positions within sectors that demonstrate return on investment potential. Business partnerships throughout the United States and Canada provide our brands many markets to expand into and produce consistently high growth rates for the next decade. The company can be found at: www.ibrandscorporation.com Safe Harbor StatementThis release includes "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E and/or 27E of the Securities Exchange Act of 1934 that are based upon assumptions that in the future may prove not to have been accurate and are subject to significant risks and uncertainties, including statements as to the future performance of the company and the risks and uncertainties detailed from time to time in reports filed by the company with the Securities and Exchange Commission. Statements contained in this release that are not historical facts may be deemed to be forward-looking statements. Investors are cautioned that forward-looking statements are inherently uncertain. Although the company believes that the expectations reflected in its forward-looking statements are reasonable, it can give no assurance that such expectations or any of its forward-looking statements will prove to be correct. Factors that could cause results to differ include, but are not limited to, the company's ability to raise necessary financing, retention of key personnel, timely delivery of inventory from the company's suppliers, timely product development, product acceptance, and the impact of competitive services and products, in addition to general economic risks and uncertainties. Sources: https://www.globenewswire.com/news-release/2020/11/17/2128654/0/en/Ontario-Bandits-Football-Club-Joins-National-Arena-League.html https://www.nationalarenaleague.com/ https://www.prnewswire.com/news-releases/therapeutic-solutions-international-enters-into-multi-million-dollar-master-sales-agreement-with-publicly-traded-ibrands-corporation-300990293.html https://mynanostilbene.com/nanopsa/ https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5412295/ https://www.labroots.com/trending/cannabis-sciences/18324/nanotechnology-makes-medicinal-cannabis-effective https://www.globenewswire.com/news-release/2019/07/29/1892915/0/en/NanoStilbene-Nutraceutical-Shown-to-Increase-Ability-of-Cyclophosphamide-Chemotherapy-to-Suppress-Cancer.html [1] Dhar et al. Oncotarget. 2015 Sep 29;6(29):27214-26. [2] Wakimoto et al. Differential Anticancer Activity of Pterostilbene Against Three Subtypes of Human Breast Cancer Cells. Anticancer Res. 2017 Nov;37(11):6153-6159. [3] Huynh et al. Pterostilbene suppressed irradiation-resistant glioma stem cells by modulating GRP78/miR-205 axis. J Nutr Biochem. 2015 May;26(5):466-75. [4] Qian et al. Pterostilbene inhibits MTA1/HDAC1 complex leading to PTEN acetylation in hepatocellular carcinoma. Biomed Pharmacother. 2018 May;101:852-859. [5] Feng et al. Pterostilbene Inhibits the Growth of Human Esophageal Cancer Cells by Regulating Endoplasmic Reticulum Stress. Cell Physiol Biochem. 2016;38(3):1226-44. [6] Benlloch et al. Pterostilbene Decreases the Antioxidant Defenses of Aggressive Cancer Cells In Vivo: A Physiological Glucocorticoids- and Nrf2-Dependent Mechanism. Antioxid Redox Signal. 2016 Jun 10;24(17):974-90. CONTACT: For more information please contact: investorrelationsdesk@gmail.com

  • GlobeNewswire

    iBrands Corporation Becomes Product Sponsor For Professional Football Franchise

    LAS VEGAS, May 03, 2021 (GLOBE NEWSWIRE) -- iBrands Corporation (OTC PINK: IBRC) ("the Company"), a diversified holding and branding company, announces that through its subsidiary iBrands Farms, has become a product sponsor for the Ontario Bandits Football Club, respectively. The Ontario Bandits became the newest expansion team for the National Arena League (NAL) as the league previously announced recent expansion with the Albany Empire as its New York based franchise this previous October. The Bandits will be the seventh team entering the 2021 season with the NAL joining the Jacksonville Sharks, Columbus Lions, Carolina Cobras, Orlando Predators, Jersey Flight, and the Albany Empire. The company will be providing its immune boosting nutraceutical supplement QuadraMune to the players and staff of the Ontario Bandits as the state of California begins its gradual reopening. QuadraMune™ is a nutritional supplement which has previously been demonstrated to possess anti-inflammatory and immune modulatory activity based on in vitro and pilot in vivo studies. The current clinical trial aims to assess in a 500 volunteer trial the efficacy of QuadraMune™ in reducing infection in individuals at high risk of COVID-19. iBrands Corporation entered into a Master Sales Agreement with Therapeutic Solutions Inc. (“TSOI”) to distribute the nutraceutical line of products developed by TSOI for sales through its iBrands Farms subsidiary. Products to be included in the Master Sales Agreement currently consist of NanoStilbene, NanoPSA, Nano Plus, Nano Cannabidiol, ProJuvenol, and Immune Booster QuadraMune. A clinical trial has been granted ClinicalTrials.gov Identifier: NCT04421391 and is now on the Federal Clinical Trial registry: https://www.clinicaltrials.gov/ct2/show/NCT04421391. Other exciting developments from this license include the public information release from TSOI includes “QuadraMune Reduces Myeloid Suppressor Cells in 4T1 Mouse Model of Breast Cancer New Patent Filing Suggests Novel Mechanism of Immune Boosting Nutraceutical Can Augment Efficacy of Cancer Immunotherapy.” and, “Positive QuadraMune™ Clinical Trial Data,” which suggests data from its clinical trial demonstrating an almost doubling of immune cell activity in healthy volunteers which were ingesting QuadraMune™ daily for a week. Investigators analyzed blood for production of an immunological protein called "interleukin-2" after stimulation with anti-CD3 and anti-CD28. The substantial increase in interleukin-2 is believed to predict that immunological cells such as T cells and NK cells, which are needed to fight viruses such as SARS-CoV-2, possess enhanced function after QuadraMune™ administration. Currently the Company is running a clinical trial on QuadraMune™ for preventing COVID-19 in health care workers. The clinical trial is listed on the National Institutes of Health Clinical Trial Database at www.clinicaltrials.gov. These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease. About the Ontario Bandits Football Club The Ontario Bandits Football Club is a sports and entertainment property located in Southern California that is committed to exhibiting hard work and excellence both on the field and off in our respective communities. For more information please go to: https://www.toyota-arena.com/teams/detail/ontario-banditshttps://www.ontariobandits.com/ About Therapeutic Solutions International, Inc. Therapeutic Solutions International is focused on immune modulation for the treatment of several specific diseases. Immune modulation refers to the ability to upregulate (make more active) or downregulate (make less active) one's immune system. The Company's corporate website is at www.therapeuticsolutionsint.com and our e-commerce is at www.youcanordernow.com and for additional info on NanoStilbene visit www.nanostilbene.com. About iBrands Farms iBrands Farms is a vertically integrated agribusiness focused on the production and sale of products with naturally occurring cannabinoids. Our mission is to efficiently deliver the highest quality industrial hemp-derived cannabinoid products and unique nutraceuticals to our customers, both retail and wholesale. The company can be found at www.ibrandsfarms.com About iBrands Corporation iBrands Corporation, Inc. is a holding and branding company that acquires and operates niche market brands that have unique market positions within sectors that demonstrate return on investment potential. Business partnerships throughout the United States and Canada provide our brands many markets to expand into and produce consistently high growth rates for the next decade. The company can be found at: www.ibrandscorporation.com Safe Harbor StatementThis release includes "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E and/or 27E of the Securities Exchange Act of 1934 that are based upon assumptions that in the future may prove not to have been accurate and are subject to significant risks and uncertainties, including statements as to the future performance of the company and the risks and uncertainties detailed from time to time in reports filed by the company with the Securities and Exchange Commission. Statements contained in this release that are not historical facts may be deemed to be forward-looking statements. Investors are cautioned that forward-looking statements are inherently uncertain. Although the company believes that the expectations reflected in its forward-looking statements are reasonable, it can give no assurance that such expectations or any of its forward-looking statements will prove to be correct. Factors that could cause results to differ include, but are not limited to, the company's ability to raise necessary financing, retention of key personnel, timely delivery of inventory from the company's suppliers, timely product development, product acceptance, and the impact of competitive services and products, in addition to general economic risks and uncertainties. Sources: https://www.globenewswire.com/news-release/2020/11/17/2128654/0/en/Ontario-Bandits-Football-Club-Joins-National-Arena-League.html https://www.nationalarenaleague.com/ https://www.twincities.com/2021/03/05/california-to-let-major-league-baseball-disneyland-reopen/ https://ballparkdigest.com/2021/03/08/california-mlb-teams-cleared-for-fans-in-the-stands/ https://www.latimes.com/california/story/2021-05-01/minimal-vaccine-hesitancy-fuels-californias-covid-recovery https://www.yahoo.com/lifestyle/ibrands-corporation-adds-immune-booster-131010087.html https://www.globenewswire.com/news-release/2020/06/17/2049529/0/en/iBrands-Corporation-Announces-Clinical-Trial-For-Immune-Booster-Product.html https://www.marketscreener.com/IBRANDS-CORP-13534846/news/iBrands-Corporation-Reports-QuadraMune-Reduces-Myeloid-Suppressor-Cells-in-4T1-Mouse-Model-of-Breast-30805640/?utm_medium=RSS&utm_source=googlenews&utm_content=20200622 https://www.nasdaq.com/press-release/ibrands-corporation-reports-reduction-of-brain-inflammation-depression-associated CONTACT: For more information please contact: investorrelationsdesk@gmail.com